2.0M XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Nayak Sanjay | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 6.84 per share. | 24 Feb 2025 | 1,895 | 283,485 (0%) | 0% | 6.8 | 12,962 | Common Stock |
| Heier S. Jeffrey | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.87 per share. | 24 Feb 2025 | 3,061 | 265,998 (0%) | 0% | 6.9 | 21,029 | Common Stock |
| Peter Kaiser | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 6.87 per share. | 24 Feb 2025 | 3,009 | 210,078 (0%) | 0% | 6.9 | 20,672 | Common Stock |
| Donald Notman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 115,000 | 308,444 (0%) | 0% | 0 | Common Stock | |
| Donald Notman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 344,115 | 344,115 | - | - | Stock Option (Right to Buy) | |
| Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 79,000 | 220,666 (0%) | 0% | 0 | Common Stock | |
| Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 237,000 | 237,000 | - | - | Stock Option (Right to Buy) | |
| Sanjay Nayak | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 334,000 | 334,000 | - | - | Stock Option (Right to Buy) | |
| Sanjay Nayak | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 111,000 | 285,380 (0%) | 0% | 0 | Common Stock | |
| Donald Notman | See Remarks | Sale of securities on an exchange or to another person at price $ 7.84 per share. | 31 Jan 2025 | 6,301 | 204,563 (0%) | 0% | 7.8 | 49,400 | Common Stock |
| Donald Notman | See Remarks | Sale of securities on an exchange or to another person at price $ 7.81 per share. | 31 Jan 2025 | 11,119 | 193,444 (0%) | 0% | 7.8 | 86,839 | Common Stock |
| Jeffrey S. Heier | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 25 Nov 2024 | 2,948 | 269,059 (0%) | 0% | 9.0 | 26,561 | Common Stock |
| Sanjay Nayak | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 25 Nov 2024 | 1,814 | 174,380 (0%) | 0% | 9 | 16,326 | Common Stock |
| Peter Kaiser | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 25 Nov 2024 | 2,897 | 213,087 (0%) | 0% | 9.0 | 26,102 | Common Stock |
| Todd Anderman | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2024 | 296,500 | 296,500 | - | - | Stock Option (Right to Buy) | |
| Todd Anderman | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2024 | 98,700 | 98,700 (0%) | 0% | 0 | Common Stock | |
| Jeffrey S. Heier | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey S. Heier | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 100,000 | 272,007 (0%) | 0% | 0 | Common Stock | |
| Peter Kaiser | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Peter Kaiser | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 100,000 | 215,984 (0%) | 0% | 0 | Common Stock | |
| Donald Notman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 11,034 | 208,988 (0%) | 0% | 0 | Common Stock | |
| Donald Notman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 33,602 | 33,602 | - | - | Stock Option (Right to Buy) | |
| Sanjay Nayak | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 9.02 per share. | 23 Aug 2024 | 1,832 | 176,194 (0%) | 0% | 9.0 | 16,525 | Common Stock |
| Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 12,000 | 36,000 (0%) | 0% | 0 | Common Stock | |
| Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 12,000 | 32,933 (0%) | 0% | 0 | Common Stock | |
| Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Charles Warden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 12,000 | 72,464 (0%) | 0% | 0 | Common Stock | |
| Charles Warden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 12,000 | 37,433 (0%) | 0% | 0 | Common Stock | |
| Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Seung Suh Hong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Seung Suh Hong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 12,000 | 32,933 (0%) | 0% | 0 | Common Stock | |
| Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 141,666 | 141,666 (0%) | 0% | 0 | Common Stock | |
| Nadia Waheed | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 425,000 | 425,000 | - | - | Stock Option (Right to Buy) | |
| Sanjay Nayak | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 5.84 per share. | 23 May 2024 | 2,274 | 178,026 (0%) | 0% | 5.8 | 13,280 | Common Stock |
| Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 12,000 | 162,704 (0%) | 0% | 0 | Common Stock | |
| Richard L. Lindstrom | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 18,939 | 0 | - | - | Stock Option (Right to Buy) | |
| Richard L. Lindstrom | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.80 per share. | 27 Feb 2024 | 11,363 | 150,704 (0%) | 0% | 8.8 | 99,994 | Common Stock |
| Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Richard L. Lindstrom | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.80 per share. | 27 Feb 2024 | 18,939 | 139,341 (0%) | 0% | 8.8 | 166,663 | Common Stock |
| Richard L. Lindstrom | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 11,363 | 0 | - | - | Stock Option (Right to Buy) | |
| Sanjay Nayak | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 80,300 | 180,300 (0%) | 0% | 0 | Common Stock | |
| Nayak Sanjay | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 244,550 | 244,550 | - | - | Stock Option (Right to Buy) | |
| Philip Strassburger C. | General Counsel | Sale of securities on an exchange or to another person at price $ 4.86 per share. | 03 Feb 2024 | 6,029 | 161,493 (0%) | 0% | 4.9 | 29,301 | Common Stock |
| Christopher G. White | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2024 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Notman Donald | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.86 per share. | 03 Feb 2024 | 6,212 | 195,356 (0%) | 0% | 4.9 | 30,190 | Common Stock |
| Rabia Ozden Gurses | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Donald Notman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2024 | 61,636 | 201,568 (0%) | 0% | 0 | Common Stock | |
| Gurses Ozden Rabia | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.86 per share. | 03 Feb 2024 | 6,346 | 153,054 (0%) | 0% | 4.9 | 30,842 | Common Stock |
| White G. Christopher | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 4.86 per share. | 03 Feb 2024 | 5,910 | 123,689 (0%) | 0% | 4.9 | 28,723 | Common Stock |
| C. Antony Mattessich | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.86 per share. | 03 Feb 2024 | 19,642 | 588,701 (1%) | 0% | 4.9 | 95,460 | Common Stock |
| Mattessich C. Antony | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2024 | 180,400 | 608,343 (1%) | 0% | 0 | Common Stock | |
| Christopher G. White | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2024 | 39,980 | 129,599 (0%) | 0% | 0 | Common Stock | |
| Donald Notman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2024 | 185,000 | 185,000 | - | - | Stock Option (Right to Buy) | |
| Antony Mattessich C. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2024 | 549,400 | 549,400 | - | - | Stock Option (Right to Buy) | |
| Strassburger C. Philip | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2024 | 58,304 | 167,522 (0%) | 0% | 0 | Common Stock | |
| Gurses Ozden Rabia | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2024 | 66,633 | 159,400 (0%) | 0% | 0 | Common Stock | |
| Strassburger Philip C. | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2024 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Philip C. Strassburger | General Counsel | Sale of securities on an exchange or to another person at price $ 4.95 per share. | 31 Jan 2024 | 6,831 | 109,218 (0%) | 0% | 4.9 | 33,813 | Common Stock |
| Gurses Rabia Ozden | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.95 per share. | 31 Jan 2024 | 7,764 | 92,767 (0%) | 0% | 5.0 | 38,432 | Common Stock |
| Mattessich Antony C. | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.95 per share. | 31 Jan 2024 | 18,338 | 427,943 (0%) | 0% | 4.9 | 90,773 | Common Stock |
| G. Christopher White | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 4.95 per share. | 31 Jan 2024 | 5,147 | 89,619 (0%) | 0% | 5.0 | 25,478 | Common Stock |
| Notman Donald | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.95 per share. | 31 Jan 2024 | 6,433 | 139,932 (0%) | 0% | 4.9 | 31,843 | Common Stock |
| Jeffrey S. Heier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2023 | 17,350 | 17,350 | - | - | Stock Option (Right to Buy) | |
| Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2023 | 72,000 | 72,000 | - | - | Stock Option (Right to Buy) | |
| Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2023 | 24,000 | 24,000 (0%) | 0% | 0 | Common Stock | |
| Rabia Gurses Ozden | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.93 per share. | 07 Jul 2023 | 832 | 100,531 (0%) | 0% | 4.9 | 4,102 | Common Stock |
| Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,000 | 20,933 (0%) | 0% | 0 | Common Stock | |
| Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,000 | 120,402 (0%) | 0% | 0 | Common Stock | |
| Charles Warden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,000 | 60,464 (0%) | 0% | 0 | Common Stock | |
| Charles Warden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey S. Heier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,000 | 59,933 (0%) | 0% | 0 | Common Stock | |
| Jeffrey S. Heier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,000 | 25,433 (0%) | 0% | 0 | Common Stock | |
| Seung Suh Hong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,000 | 20,933 (0%) | 0% | 0 | Common Stock | |
| Seung Suh Hong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Christopher G. White | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 4.24 per share. | 06 Feb 2023 | 5,829 | 94,766 (0%) | 0% | 4.2 | 24,715 | Common Stock |
| Antony C. Mattessich | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.24 per share. | 06 Feb 2023 | 19,669 | 446,281 (0%) | 0% | 4.2 | 83,397 | Common Stock |
| Donald Notman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.24 per share. | 06 Feb 2023 | 6,476 | 139,387 (0%) | 0% | 4.2 | 27,458 | Common Stock |
| Rabia Gurses Ozden | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.24 per share. | 06 Feb 2023 | 6,416 | 101,363 (0%) | 0% | 4.2 | 27,204 | Common Stock |
| Philip C. Strassburger | General Counsel | Sale of securities on an exchange or to another person at price $ 4.24 per share. | 06 Feb 2023 | 6,181 | 109,071 (0%) | 0% | 4.2 | 26,207 | Common Stock |
| Christopher G. White | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 133,333 | 133,333 | - | - | Stock Option (Right to Buy) | |
| Christopher G. White | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 44,444 | 100,595 (0%) | 0% | 0 | Common Stock | |
| Antony C. Mattessich | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 176,300 | 465,950 (0%) | 0% | 0 | Common Stock | |
| Antony C. Mattessich | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 536,900 | 536,900 | - | - | Stock Option (Right to Buy) | |
| Donald Notman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 55,556 | 145,863 (0%) | 0% | 0 | Common Stock | |
| Donald Notman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 166,667 | 166,667 | - | - | Stock Option (Right to Buy) | |
| Rabia Gurses Ozden | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 166,667 | 166,667 | - | - | Stock Option (Right to Buy) | |
| Rabia Gurses Ozden | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 55,556 | 107,779 (0%) | 0% | 0 | Common Stock | |
| Rabia Gurses Ozden | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Philip C. Strassburger | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 166,667 | 166,667 | - | - | Stock Option (Right to Buy) | |
| Philip C. Strassburger | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 55,556 | 115,252 (0%) | 0% | 0 | Common Stock | |
| Jeffrey S. Heier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2022 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,933 | 8,933 (0%) | 0% | 0 | Common Stock | |
| Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 26,800 | 26,800 | - | - | Stock Option (Right to Buy) | |
| Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,933 | 108,402 (0%) | 0% | 0 | Common Stock | |
| Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 26,800 | 26,800 | - | - | Stock Option (Right to Buy) | |
| Charles Warden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,933 | 48,464 (0%) | 0% | 0 | Common Stock | |
| Charles Warden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 26,800 | 26,800 | - | - | Stock Option (Right to Buy) | |
| Jeffrey S. Heier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,933 | 47,933 (0%) | 0% | 0 | Common Stock | |
| Jeffrey S. Heier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 26,800 | 26,800 | - | - | Stock Option (Right to Buy) | |
| Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 26,800 | 26,800 | - | - | Stock Option (Right to Buy) | |
| Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,933 | 13,433 (0%) | 0% | 0 | Common Stock | |
| Seung Suh Hong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,933 | 8,933 (0%) | 0% | 0 | Common Stock | |
| Seung Suh Hong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 26,800 | 26,800 | - | - | Stock Option (Right to Buy) | |
| Richard L. Lindstrom | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2022 | 9,469 | 0 | - | - | Stock Option (Right to Buy) | |
| Richard L. Lindstrom | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.22 per share. | 12 May 2022 | 9,469 | 99,469 (0%) | 0% | 1.2 | 11,552 | Common Stock |
| Jeffrey S. Heier | Director | Purchase of securities on an exchange or from another person at price $ 3.05 per share. | 12 May 2022 | 15,000 | 39,000 (0%) | 0% | 3.1 | 45,750 | Common Stock |
| Christopher G. White | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Christopher G. White | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 50,000 | 52,127 (0%) | 0% | 0 | Common Stock | |
| Michael H. Goldstein | President, Ophthalmology & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 63,333 | 313,335 (0%) | 0% | 0 | Common Stock | |
| Michael H. Goldstein | President, Ophthalmology & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 190,000 | 190,000 | - | - | Stock Option (Right to Buy) | |
| Antony C. Mattessich | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 560,200 | 560,200 | - | - | Stock Option (Right to Buy) | |
| Antony C. Mattessich | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 186,750 | 289,650 (0%) | 0% | 0 | Common Stock | |
| Donald Notman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 166,667 | 166,667 | - | - | Stock Option (Right to Buy) | |
| Donald Notman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 55,556 | 81,632 (0%) | 0% | 0 | Common Stock | |
| Philip C. Strassburger | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Philip C. Strassburger | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 50,000 | 51,810 (0%) | 0% | 0 | Common Stock | |
| Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2021 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Antony C. Mattessich | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 9.89 per share. | 20 Aug 2021 | 5,000 | 102,900 (0%) | 0% | 9.9 | 49,450 | Common Stock |
| Bruce A. Peacock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Charles Warden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey S. Heier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Seung Suh Hong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Michael H. Goldstein | President, Ophthalmology & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Antony C. Mattessich | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 455,000 | 455,000 | - | - | Stock Option (Right to Buy) | |
| Donald Notman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 190,000 | 190,000 | - | - | Stock Option (Right to Buy) | |
| Patricia Kitchen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 220,000 | 220,000 | - | - | Stock Option (Right to Buy) | |
| Philip C. Strassburger | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 51,900 | 51,900 | - | - | Stock Option (Right to Buy) | |
| Charles Warden | Director | Other type of transaction at price $ 0.00 per share. | 15 Feb 2021 | 1,456,780 | 0 (0%) | 3% | 0 | Common Stock | |
| Charles Warden | Director | Other type of transaction at price $ 0.00 per share. | 15 Feb 2021 | 8,604 | 0 (0%) | 0% | 0 | Common Stock | |
| Charles Warden | Director | Other type of transaction at price $ 0.00 per share. | 15 Feb 2021 | 35,912 | 39,531 (0%) | 0% | 0 | Common Stock | |
| Charles Warden | Director | Other type of transaction at price $ 0.00 per share. | 15 Feb 2021 | 375,121 | 0 (0%) | 0% | 0 | Common Stock | |
| Charles Warden | Director | Other type of transaction at price $ 0.00 per share. | 15 Feb 2021 | 375,121 | 375,121 (0%) | 0% | 0 | Common Stock | |
| Philip C. Strassburger | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2020 | 350,000 | 350,000 | - | - | Stock Option (Right to Buy) | |
| Bruce A. Peacock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Charles Warden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey S. Heier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Leslie J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Seung Suh Hong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Michael H. Goldstein | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2020 | 215,000 | 215,000 | - | - | Stock Option (Right to Buy) | |
| Antony C. Mattessich | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2020 | 360,000 | 360,000 | - | - | Stock Option (Right to Buy) | |
| Donald Notman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2020 | 215,000 | 215,000 | - | - | Stock Option (Right to Buy) | |
| Patricia Kitchen | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2020 | 215,000 | 215,000 | - | - | Stock Option (Right to Buy) | |
| Patricia Kitchen | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Donald Notman | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.33 per share. | 14 Jun 2019 | 2,500 | 24,049 (0%) | 0% | 4.3 | 10,825 | Common Stock |
| Leslie J. Williams | None | Purchase of securities on an exchange or from another person at price $ 4.40 per share. | 14 Jun 2019 | 4,500 | 4,500 (0%) | 0% | 4.4 | 19,800 | Common Stock |
| Bruce A. Peacock | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2019 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Richard L. Lindstrom | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2019 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Charles Warden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2019 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey S. Heier | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2019 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Seung Suh Hong | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2019 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Amarpreet Sawhney | Director, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 3.02 per share. | 06 Jun 2019 | 65,468 | 1,056,031 (2%) | 0% | 3.0 | 197,713 | Common Stock |
| Amarpreet Sawhney | Director, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 2.80 per share. | 06 Jun 2019 | 59,000 | 990,563 (2%) | 0% | 2.8 | 165,200 | Common Stock |
| Antony C. Mattessich | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 2.81 per share. | 06 Jun 2019 | 40,000 | 97,900 (0%) | 0% | 2.8 | 112,400 | Common Stock |
| Amarpreet Sawhney | Director, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 2.92 per share. | 04 Jun 2019 | 12,928 | 898,711 (1%) | 0% | 2.9 | 37,750 | Common Stock |
| Amarpreet Sawhney | Director, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 2.91 per share. | 04 Jun 2019 | 32,852 | 931,563 (1%) | 0% | 2.9 | 95,599 | Common Stock |
| Michael H. Goldstein | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.51 per share. | 28 May 2019 | 12,000 | 25,686 (0%) | 0% | 2.5 | 30,120 | Common Stock |
| Leslie J. Williams | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2019 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey S. Heier | None | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 15 Mar 2019 | 24,000 | 24,000 (0%) | 0% | 4.2 | 99,600 | Common Stock |
| Michael H. Goldstein | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 15 Mar 2019 | 10,000 | 13,686 (0%) | 0% | 4.2 | 41,500 | Common Stock |
| Richard L. Lindstrom | None | Purchase of securities on an exchange or from another person at price $ 4.33 per share. | 13 Mar 2019 | 56,441 | 100,000 (0%) | 0% | 4.3 | 244,390 | Common Stock |
| Daniel M. Bollag | Sr. VP Reg. Affairs & Quality | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 180,000 | 180,000 | - | - | Stock Option (Right to Buy) | |
| Amarpreet Sawhney | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Michael H. Goldstein | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Antony C. Mattessich | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Donald Notman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Kevin F. Hanley | Sr. VP Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Kevin F. Hanley | See Remarks | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 14 Dec 2018 | 10,000 | 20,000 (0%) | 0% | 5.5 | 55,000 | Common Stock |
| Kevin F. Hanley | SEE REMARKS | Purchase of securities on an exchange or from another person at price $ 5.60 per share. | 10 Dec 2018 | 10,000 | 10,000 (0%) | 0% | 5.6 | 56,000 | Common Stock |
| Daniel M. Bollag | See Remarks | Purchase of securities on an exchange or from another person at price $ 5.76 per share. | 06 Dec 2018 | 17,400 | 42,100 (0%) | 0% | 5.8 | 100,224 | Common Stock |
| Antony C. Mattessich | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 5.95 per share. | 20 Aug 2018 | 20,000 | 57,900 (0%) | 0% | 6.0 | 119,000 | Common Stock |
| Donald Notman | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 6.29 per share. | 14 Aug 2018 | 12,500 | 17,300 (0%) | 0% | 6.3 | 78,625 | Common Stock |
| Antony C. Mattessich | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 6.23 per share. | 10 Aug 2018 | 16,900 | 37,900 (0%) | 0% | 6.2 | 105,287 | Common Stock |
| Bruce A. Peacock | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2018 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Richard L. Lindstrom | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2018 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| W. James O'Shea | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2018 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Charles Warden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2018 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Jaswinder Chadha | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2018 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey S. Heier | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2018 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Kevin F. Hanley | Senior V.P.,Tech Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2018 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Daniel M. Bollag | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2018 | 51,100 | 51,100 | - | - | Stock Option (Right to Buy) | |
| Amarpreet Sawhney | Director, Exec Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2018 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
| Michael H. Goldstein | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2018 | 83,500 | 83,500 | - | - | Stock Option (Right to Buy) | |
| Antony C. Mattessich | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2018 | 360,000 | 360,000 | - | - | Stock Option (Right to Buy) | |
| Donald Notman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2018 | 83,500 | 83,500 | - | - | Stock Option (Right to Buy) | |
| Amarpreet Sawhney | Director, Exec Chairman of the Board, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2017 | 83,011 | 0 | - | - | Stock Option (Right to Buy) | |
| Amarpreet Sawhney | Director, Exec Chairman of the Board, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2017 | 106,382 | 0 | - | - | Stock Option (Right to Buy) | |
| Amarpreet Sawhney | Director, Exec Chairman of the Board, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.49 per share. | 21 Dec 2017 | 83,011 | 779,401 (2%) | 0% | 2.5 | 206,697 | Common Stock |
| Amarpreet Sawhney | Director, Exec Chairman of the Board, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.73 per share. | 21 Dec 2017 | 106,382 | 885,783 (3%) | 0% | 2.7 | 290,423 | Common Stock |
| Antony C. Mattessich | Director, President and C.E.O. | Purchase of securities on an exchange or from another person at price $ 4.29 per share. | 12 Dec 2017 | 21,000 | 21,000 (0%) | 0% | 4.3 | 90,090 | Common Stock |
| Daniel M. Bollag | See Remarks | Purchase of securities on an exchange or from another person at price $ 3.93 per share. | 07 Dec 2017 | 24,700 | 24,700 (0%) | 0% | 3.9 | 97,071 | Common Stock |
| Donald Notman | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 07 Dec 2017 | 4,800 | 4,800 (0%) | 0% | 4 | 19,200 | Common Stock |
| Amarpreet Sawhney | Director, Exec. Chairman of the Board, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.18 per share. | 16 Nov 2017 | 19,000 | 696,390 (2%) | 0% | 5.2 | 98,420 | Common Stock |
| Michael H. Goldstein | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2017 | 135,000 | 135,000 | - | - | Stock Option (Right to Buy) | |
| Donald Notman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2017 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Daniel M. Bollag | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2017 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| Antony C. Mattessich | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2017 | 590,000 | 590,000 | - | - | Stock Option (Right to Buy) | |
| Bruce A. Peacock | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| Richard L. Lindstrom | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| W. James O'Shea | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| James Garvey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| Charles Warden | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| Jaswinder Chadha | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| Jeffrey S. Heier | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| W. Bradford Smith | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2017 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Eric Ankerud | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2017 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| James Fortune | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2017 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2017 | 235,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
| Jonathan H. Talamo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2017 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Charles Andrew Hurley | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2017 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Dec 2016 | 45,300 | 677,390 | - | - | Common Stock | |
| Charles Andrew Hurley | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2016 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2016 | 58,357 | 0 | - | - | Stock Option (Right to Buy) | |
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2016 | 58,357 | 632,090 | - | - | Common Stock | |
| Jonathan H. Talamo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2016 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Jun 2016 | 10,000 | 573,733 | - | - | Common Stock | |
| Bruce A. Peacock | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2016 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| W. James O'Shea | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2016 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| Richard L. Lindstrom | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2016 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| James Garvey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2016 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| Charles Warden | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2016 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| Jaswinder Chadha | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2016 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| Jeffrey S. Heier | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2016 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| W. Bradford Smith | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2016 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Eric Ankerud | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2016 | 57,500 | 57,500 | - | - | Stock Option (Right to Buy) | |
| James Fortune | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2016 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2016 | 235,000 | 235,000 | - | - | Stock Option (Right to Buy) | |
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 17 Nov 2015 | 10,000 | 563,733 | - | - | Common Stock | |
| W. James O'Shea | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2015 | 11,363 | 11,363 | - | - | Stock Option (Right to Buy) | |
| James Fortune | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Sep 2015 | 9,470 | 112,060 | - | - | Common Stock | |
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Sep 2015 | 3,672 | 553,733 | - | - | Common Stock | |
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Sep 2015 | 11,328 | 550,061 | - | - | Common Stock | |
| Jeffrey S. Heier | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2015 | 11,363 | 11,363 | - | - | Stock Option (Right to Buy) | |
| Charles Warden | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Jun 2015 | 318,122 | 2,202,377 | - | - | Common Stock | |
| Charles Warden | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Jun 2015 | 1,878 | 13,007 | - | - | Common Stock | |
| Bruce A. Peacock | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2015 | 5,681 | 5,681 | - | - | Stock Option (Right to Buy) | |
| Richard L. Lindstrom | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2015 | 5,681 | 5,681 | - | - | Stock Option (Right to Buy) | |
| James Garvey | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2015 | 5,681 | 5,681 | - | - | Stock Option (right to buy) | |
| Charles Warden | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2015 | 5,681 | 5,681 | - | - | Stock Option (Right to Buy) | |
| Jaswinder Chadha | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2015 | 5,681 | 5,681 | - | - | Stock Option (Right to Buy) | |
| Charles Warden | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 Jun 2015 | 424,494 | 2,520,499 | - | - | Common Stock | |
| Charles Warden | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 Jun 2015 | 2,506 | 14,885 | - | - | Common Stock | |
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2015 | 51,491 | 58,357 | - | - | Stock Option (Right to Buy) | |
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2015 | 51,491 | 538,733 | - | - | Common Stock | |
| Richard L. Lindstrom | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2015 | 18,939 | 37,878 | - | - | Common Stock | |
| Richard L. Lindstrom | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2015 | 5,681 | 43,559 | - | - | Common Stock | |
| Richard L. Lindstrom | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2015 | 5,681 | 0 | - | - | Stock Option (right to buy) | |
| Richard L. Lindstrom | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2015 | 18,939 | 0 | - | - | Stock Option (right to buy) | |
| W. Bradford Smith | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2015 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Eric Ankerud | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2015 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| James Fortune | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2015 | 79,000 | 79,000 | - | - | Stock Option (Right to Buy) | |
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2015 | 170,000 | 170,000 | - | - | Stock Option (Right to Buy) | |
| Bruce A. Peacock | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2014 | 11,363 | 11,363 | - | - | Stock Option (Right to Buy) | |
| Richard L. Lindstrom | None | 30 Jul 2014 | 50,000 | 0 | - | - | Series A Preferred Stock | ||
| Richard L. Lindstrom | None | 30 Jul 2014 | 18,939 | 18,939 | - | - | Common Stock | ||
| Charles Warden | None | 30 Jul 2014 | 198,826 | 0 | - | - | Series A Preferred Stock | ||
| Charles Warden | None | 30 Jul 2014 | 1,174 | 0 | - | - | Series A Preferred Stock | ||
| Charles Warden | None | 30 Jul 2014 | 1,619,102 | 0 | - | - | Series B Preferred Stock | ||
| Charles Warden | None | 30 Jul 2014 | 9,563 | 0 | - | - | Series B Preferred Stock | ||
| Charles Warden | None | 30 Jul 2014 | 2,433,816 | 0 | - | - | Series C Preferred Stock | ||
| Charles Warden | None | 30 Jul 2014 | 14,372 | 0 | - | - | Series C Preferred Stock | ||
| Charles Warden | None | 30 Jul 2014 | 3,523,039 | 0 | - | - | Series D Preferred Stock | ||
| Charles Warden | None | 30 Jul 2014 | 20,804 | 0 | - | - | Series D Preferred Stock | ||
| Charles Warden | None | 30 Jul 2014 | 2,944,993 | 2,944,993 | - | - | Common Stock | ||
| Charles Warden | None | 30 Jul 2014 | 17,391 | 17,391 | - | - | Common Stock | ||
| Jaswinder Chadha | None | 30 Jul 2014 | 100,000 | 0 | - | - | Series A Preferred Stock | ||
| Jaswinder Chadha | None | 30 Jul 2014 | 27,144 | 0 | - | - | Series B Preferred Stock | ||
| Jaswinder Chadha | None | 30 Jul 2014 | 117,243 | 0 | - | - | Series C Preferred Stock | ||
| Jaswinder Chadha | None | 30 Jul 2014 | 92,570 | 130,448 | - | - | Common Stock | ||
| Eric Ankerud | See Remarks | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Jul 2014 | 1,000 | 78,651 | - | - | Common Stock | |
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | 30 Jul 2014 | 320,836 | 0 | - | - | Series A Preferred Stock | ||
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | 30 Jul 2014 | 61,664 | 0 | - | - | Series C Preferred Stock | ||
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | 30 Jul 2014 | 243,902 | 0 | - | - | Series C Preferred Stock | ||
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | 30 Jul 2014 | 42,440 | 0 | - | - | Series C Preferred Stock | ||
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | 30 Jul 2014 | 23,357 | 487,242 | - | - | Common Stock | ||
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | 30 Jul 2014 | 213,915 | 846,377 | - | - | Common Stock | ||
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | 30 Jul 2014 | 16,075 | 394,862 | - | - | Common Stock | ||
| Amarpreet Sawhney | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Jul 2014 | 76,922 | 471,784 | - | - | Common Stock |